Using positron emission tomography (PET) to track tracer doses of methamphetamine in humans’ brains, scientists at Brookhaven Lab find that the addictive and long-lasting effects of this increasingly prevalent drug can be explained in part by its pharmacokinetics — the rate at which it enters and clears the brain, and its distribution.